SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

14 Feb 2025 Evaluate
Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma. Share Price

2178.80 -1.85 (-0.08%)
24-Jun-2026 14:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1875.15
Dr. Reddys Labs. 1327.30
Cipla 1441.50
Zydus Lifesciences 1102.00
Lupin 2373.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: